ARG70375
Influenza A H7N9 nucleocapsid recombinant protein (A/Shanghai/02/2013) (His-tagged, N-ter)
Influenza A H7N9 nucleocapsid recombinant protein (A/Shanghai/02/2013) (His-tagged, N-ter) for SDS-PAGE
Overview
Product Description | E. coli expressed, His-tagged (N-ter) Influenza A H7N9 nucleocapsid recombinant protein (A/Shanghai/02/2013) |
---|---|
Tested Application | SDS-PAGE |
Target Name | Influenza A H7N9 nucleocapsid protein |
Species | Virus |
A.A. Sequence | Met1 - Asn498 |
Expression System | E. coli |
Protein Full Name | Influenza A H7N9 nucleocapsid protein |
Properties
Form | Powder |
---|---|
Purity | >95% (by SDS-PAGE) |
Buffer | PBS (pH 7.4) |
Reconstitution | It is recommended to reconstitute the lyophilized protein in sterile water to a concentration not <200 μg/mL and incubate the stock solution for at least 20 min at room temperature to make sure the protein is dissolved completely. |
Storage Instruction | For long term, lyophilized protein should be stored at -20°C or -80°C. After reconstitution, aliquot and store at -20°C or -80°C for up to one month. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. |
Note | For laboratory research only, not for drug, diagnostic or other use. |
Bioinformation
Background | Human infections with an Asian lineage avian influenza A(H7N9) virus (“Asian H7N9”) were first reported in China in March 2013. Annual epidemics of sporadic human infections with Asian H7N9 viruses in China have been reported since that time. China is currently experiencing its 6th epidemic of Asian H7N9 human infections. Since October 1, 2017, there have been only 3 reported human infections. |
---|
Images (1) Click the Picture to Zoom In